Skip to main content

Table 2 Clinical measurements at T1 (baseline); T2 and T3 for the two study groups †

From: Reducing resistance to treatment, through group intervention, improves clinical measurements in patients with type 2 diabetes

Time

Group 1

Group 0

P value

 

N

Mean

SD

N

Mean

SD

 

HbA1C

T1

89

7.5

1.8

41

7.1

1.7

0.210

T2

92

7.1

1.4

38

6.9

1.26

0.461

T3

58

7.0

1.2

26

7.1

1.4

0.816

HDL

T1

90

45.5

11.3

40

47.3

13.5

0.447

T2

91

45.0

11.1

39

47.7

12.9

0.265

T3

52

43.6

9.5

26

47.9

12.8

0.138

LDL

T1

90

93.4

29.3

40

96.8

29.0

0.538

T2

91

91.8

32.6

39

92.1

38.2

0.965

T3

52

94.5

32.0

26

92.8

34.7

0.842

TG

T1

90

155.4

70.3

40

162.5

89.5

0.657

T2

91

154.5

70.7

39

176.5

142.5

0.364

T3

53

180.1

97.8

26

190.0

144.8

0.754

BPS

T1

90

132.0

16.9

41

131.0

17.2

0.769

T2

92

130.0

15.2

38

126.6

15.4

0.259

T3

55

129.3

13.6

23

134.1

16.3

0.223

BPD

T1

90

79.0

10.0

41

79.0

9.6

0.992

T2

92

77.6

8.9

38

76.5

9.4

0.517

T3

55

74.7

8.3

23

75.7

10.2

0.675

BMI

T1

88

30.7

5.2

41

29.8

4.9

0.362

T2

89

31.2

6.3

38

30.2

4.8

0.349

T3

58

29.9

4.7

23

29.4

4.5

0.630

  1. SD = Standard Deviation; † Study groups = Total Resistance: delta between T2 and T1 <0 = group 1; delta between T2 and T1 = >0 - group 0